Manufacturing Automation: Editorial: Advanced manufacturing key to Canada’s post-COVID future
A recent report on the future of Canada’s post-pandemic supply chain targets the advanced manufacturing sector as a prime market for growth
It was welcome news at the end of March when French-owned pharmaceutical giant Sanofi announced plans to construct a $925-million influenza vaccine manufacturing facility in Toronto — though not only for the new jobs it would bring, or the economic boost it would inject into a challenged economy coming out of COVID-19.
It also wasn’t only about Canada having domestic vaccine production in the event of another pandemic — though that is very welcome news indeed. No, Sanofi choosing to add another facility in Canada when the company also has a presence in 99 other countries showed the world that Canada is worth investing in.
Consider this: a recent report on the future of Canada’s post-pandemic supply chain targets the advanced manufacturing sector as a prime market for growth — and a place where new automation solutions can take centre stage.